https://www.marketscreener.com/quote/stock/MEDICINOVA-INC-38688/news/MediciNova-Announces-New-Data-and-Results-of-a-Phase-2-Clinical-Trial-of-MN-166-ibudilast-in-Gliob-45394073/?utm_source=telegram&utm_medium=social&utm_campaign=share